Researchers have identified hundreds of new and known microRNAs in the domestic dog genome, a finding that could contribute to disease research.
The FDA, journals, and even payors are encouraging labs to deposit variant data in public databases, but collaboration is needed to resolve interpretation discrepancies.
Sanger Institute researchers analyzed the genomes and mutational signatures of 560 breast cancer tumors, identifying new ways to classify the disease.
Questions remain about how the €6.7 billion ($7.6 billion) pledged for the implementation of the European Open Science Cloud over the next four years will be spent.
The companies plan to combine their platforms and research to launch new clinical assays and develop procedures and therapeutics to treat pain.
Some 20 percent of 650 clinical germlines analyzed since the project launched last year have had at least one variant associated with increased cancer risk.
The company's software is able to reduce sequence file sizes by up to fivefold, in turn reducing storage costs four- to fivefold.
The revenue spike was due to an increase in the number of Atlas molecular testing platforms placed with commercial customers.
In Science this week: CRISPR-based approach to identify gene variants, and more.
Stat News profiles the Wellcome Trust's Jeremy Farrar.
France's research minister tells Nature News that he hopes to simplify the research bureaucracy and improve funding.
A recent study examines how a paper, despite being retracted, can influence its field, Retraction Watch reports.
This webinar highlights important features and demonstrates the practical aspects of using the NCBI BLAST service.
This on-demand webinar demonstrates how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.
This online seminar demonstrates how RNA-seq analysis in a model organism can provide insights into human disease.